PWLP
ARRY

Prio Wealth Limited Partnership’s Array Biopharma Inc ARRY Stock Holding History

Prio Wealth Limited Partnership’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-60,000
Closed -$283K – 263
2014
Q4 		$283K Hold
60,000
– – 0.01% 218
2014
Q3 		$214K Hold
60,000
– – 0.01% 238
2014
Q2 		$273K Hold
60,000
– – 0.01% 218
2014
Q1 		$282K Hold
60,000
– – 0.01% 218
2013
Q4 		$300K Hold
60,000
– – 0.02% 213
2013
Q3 		$373K Hold
60,000
– – 0.02% 193
2013
Q2 		$272K Buy
+60,000
New +$323K 0.02% 212

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Prio Wealth Limited Partnership's ARRY Position: Q1 2015 in Review

Prio Wealth Limited Partnership sold out of Array Biopharma Inc (ARRY) in Q1 2015, closing a stake of 60,000 shares — an estimated $283K sold.

Prio Wealth Limited Partnership first reported a position in ARRY in Q2 2013 and held it in 7 quarters. The position peaked at $373K in Q3 2013. 133 funds tracked by Wall St. Rank hold ARRY as of Q1 2015.

  • Prio Wealth Limited Partnership reported no remaining Array Biopharma Inc position as of Q1 2015 after selling out during the quarter.
  • Prio Wealth Limited Partnership sold 60,000 Array Biopharma Inc shares in Q1 2015, an estimated $283K.
  • Prio Wealth Limited Partnership first reported a position in Array Biopharma Inc in Q2 2013 and held it in 7 quarters.
  • Prio Wealth Limited Partnership's Array Biopharma Inc position peaked at $373K in Q3 2013.
  • 133 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2015.

Based on Prio Wealth Limited Partnership's 13F filing for Q1 2015, filed 5 May 2015.